Sentry Investment Management’s Exact Sciences EXAS Stock Holding History

Sentry Investment Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-4,205	Closed	-$286K	–	470
2024 Q3	$286K	Hold	4,205	–	–	0.12%	169
2024 Q2	$178K	Sell	4,205 -2,715	-39%	-$149K	0.08%	218
2024 Q1	$478K	Hold	6,920	–	–	0.19%	131
2023 Q4	$512K	Buy	+6,920	New	+$454K	0.22%	113
2023 Q3	–	Sell	-6,205	Closed	-$583K	–	509
2023 Q2	$583K	Buy	+6,205	New	+$484K	0.22%	111
2015 Q4	–	Sell	-49,957	Closed	-$899K	–	513
2015 Q3	$899K	Buy	49,957 +15,757	+46%	+$362K	0.04%	291
2015 Q2	$1.02M	Buy	+34,200	New	+$859K	0.05%	281
2015 Q1	–	Sell	-25,000	Closed	-$686K	–	533
2014 Q4	$686K	Buy	+25,000	New	+$608K	0.03%	325

Other funds holding EXAS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sentry Investment Management's EXAS Position: Q4 2024 in Review

Sentry Investment Management sold out of Exact Sciences (EXAS) in Q4 2024, closing a stake of 4,205 shares — an estimated $286K sold.

Sentry Investment Management first reported a position in EXAS in Q4 2014 and held it in 8 quarters. The position peaked at $1.02M in Q2 2015. 594 funds tracked by Wall St. Rank hold EXAS as of Q4 2024.

Sentry Investment Management reported no remaining Exact Sciences position as of Q4 2024 after selling out during the quarter.
Sentry Investment Management sold 4,205 Exact Sciences shares in Q4 2024, an estimated $286K.
Sentry Investment Management first reported a position in Exact Sciences in Q4 2014 and held it in 8 quarters.
Sentry Investment Management's Exact Sciences position peaked at $1.02M in Q2 2015.
594 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2024.

Based on Sentry Investment Management's 13F filing for Q4 2024, filed 4 Feb 2025.